Inventor · disambiguated record
Bonnee Rubinfeld
Also filed as: RUBINFELD BONNEE
19 granted patents·14 pending applications·116 citations·filing 1990–2022
94Inventor score
Top patents by PatentIndex Score
33 records- 0195US8771966B2Immuno-PET imaging of antibodies and immunoconjugates and uses thereforGENENTECH INC·Filed 2012·Granted Jul 8, 2014·17 cites·9 claims
- 0294US7947277B2Wnt antagonists and their use in the diagnosis and treatment of Wnt-mediated disordersGENENTECH INC·Filed 2007·Granted May 24, 2011·33 cites·13 claims
- 0391US8436147B2Antibodies and immunoconjugates and uses thereforDENNIS MARK S·Filed 2007·Granted May 7, 2013·13 cites·44 claims
- 0489US8535675B2Compositions and methods for the diagnosis and treatment of tumorDENNIS MARK·Filed 2010·Granted Sep 17, 2013·9 cites·27 claims
- 0585US8889847B2Antibodies and immunoconjugates and uses thereforGENENTECH INC·Filed 2013·Granted Nov 18, 2014·5 cites·16 claims
- 0683US9593167B2Antibodies and immunoconjugates and uses thereforGENENTECH INC·Filed 2014·Granted Mar 14, 2017·4 cites·53 claims
- 0782US9632091B2Compositions and methods for prostate cancer analysisGENENTECH INC·Filed 2015·Granted Apr 25, 2017·3 cites·17 claims
- 0878US11066359B2Biodegradable surfactants and related compositions, methods and systemsL LIVERMORE NAT SECURITY LLC·Filed 2018·Granted Jul 20, 2021·1 cites·16 claims
- 0976US12110314B2PepCon proteomics standards and methods of useL LIVERMORE NAT SECURITY LLC·Filed 2022·Granted Oct 8, 2024·0 cites·18 claims
- 1074US8846041B2Anti-LRP6 antibodiesBOURHIS ERIC·Filed 2011·Granted Sep 30, 2014·6 cites·16 claims
- 1167US11492380B2PepCon proteomics standards and methods of useL LIVERMORE NAT SECURITY LLC·Filed 2020·Granted Nov 8, 2022·0 cites·13 claims
- 1266US2018251567A1Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2018·Application pending·0 cites
- 1365US9994643B2Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2016·Granted Jun 12, 2018·0 cites·25 claims
- 1465US9029511B2Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2013·Granted May 12, 2015·0 cites·23 claims
- 1565US8871911B2Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2013·Granted Oct 28, 2014·0 cites·27 claims
- 1665US2014363873A1Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2014·Application pending·0 cites
- 1764US5948643AModulators of BRCA1 activityONYX PHARMA INC·Filed 1997·Granted Sep 7, 1999·18 cites·7 claims
- 1863US2015056132A1Immuno-pet imaging of antibodies and immunoconjugates and uses thereforGENENTECH INC·Filed 2014·Application pending·0 cites
- 1963US2017121424A1Immuno-pet imaging of antibodies and immunoconjugates and uses thereforGENENTECH INC·Filed 2016·Application pending·0 cites
- 2062US2018106809A1Antibodies and immunoconjugates and uses thereforGENENTECH INC·Filed 2017·Application pending·0 cites
- 2161US2016168261A1Immuno-pet imaging of antibodies and immunoconjugates and uses thereforGENENTECH INC·Filed 2015·Application pending·0 cites
- 2261US2021403421A1Biodegradable surfactants and related compositions, methods and systemsL LIVERMORE NAT SECURITY LLC·Filed 2021·Application pending·0 cites
- 2359US2017234883A1Antibodies and immunoconjugates and uses thereforGENENTECH INC·Filed 2017·Application pending·0 cites
- 2457US2017349639A1Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disordersGENENTECH INC·Filed 2016·Application pending·0 cites
- 2554US9556267B2Anti-LRP6 antibodiesGENENTECH INC·Filed 2014·Granted Jan 31, 2017·0 cites·10 claims
- 2652US2010266593A1Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disordersGENENTECH INC·Filed 2010·Application pending·0 cites
- 2750US2012141481A1Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disordersERNST JAMES A·Filed 2012·Application pending·0 cites
- 2848US2011311534A1Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disordersERNST JAMES A·Filed 2011·Application pending·0 cites
- 2943US5763573AGTPase activating protein fragmentsCHIRON CORP·Filed 1995·Granted Jun 9, 1998·3 cites·17 claims
- 3043US2013143237A1Compositions and methods for prostate cancer analysisGENENTECH INC·Filed 2012·Application pending·0 cites
- 3140US2002115109A1Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactionsFiled 2001·Application pending·0 cites
- 3230US5830684ANative type II GAP, methods for purifying various GAPs and uses of GAPs to diagnose cancerCHIRON CORP·Filed 1990·Granted Nov 3, 1998·2 cites·7 claims
- 3330US5760203AGap gene sequencesCHIRON CORP·Filed 1994·Granted Jun 2, 1998·2 cites·39 claims
Join the waitlist — get patent alerts
Get an alert when Bonnee Rubinfeld files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →